Eli Lilly has provided new insights into retatrutide, its investigational medicine that is attracting significant attention for its potential to treat obesity, type 2 diabetes, and several obesity-related health conditions
Snchez-Villegas A, Bes-Rastrollo M, Martnez-Gonzlez MA, Serra-Majem L
In another case, a federal court granted a default judgement against an online marketer sued by Novo Nordisk, ending its unlawful practice of selling compounded "semaglutide" directly to consumers without a prescription or instructions for use, misleadingly labeling it as for "Research Use Only." Dozens of other courts have entered permanent injunctions against the entities sued by Novo Nordisk, permanently forbidding them from falsely claiming that knockoff "semaglutide" drugs: (1) are genuine Novo Nordisk medicines
Common GLP-1 injection issues: Troubleshooting Most injection site reactions are mild and temporary
it decreases the amount of the CD3 chain by inhibiting biosynthesis of this most rapidly cycling component of the TCR (78)
By 2024 it exceeded USD 15 billion and is forecast to surpass USD 50 billion by 2030 entirely driven by GLP-1/GIP peptide therapies
